Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 13/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 4/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906584 | 1.00 | CTSK (0.50) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL22749258 | 0.86 | CTSK (0.54) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL806058 | 0.86 | CTSK (0.54) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL1994082 | 0.84 | CTSK (0.34) | CTSK | |
| SCHEMBL19993318 | 0.83 | CTSK (0.49) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL13365447 | 0.78 | CTSK (0.54) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL4388619 | 0.76 | CTSK (0.43) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL18553069 | 0.76 | CTSK (0.53) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL2058674 | 0.76 | CTSK (0.53) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL963465 | 0.76 | CTSK (0.53) | CTSKCA1CA2CA7CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8198364-B2 | Poly (vinyl alcohol) polymers, uses and preparation thereof | VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) | 2012-06-12 | — | — | US | disclosed |
| US-20100038297-A1 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof | UNIVERSITE DE MONTREAL (CA) | 2010-02-18 | — | — | US | disclosed |
| EP-2029644-A1 | POLY (VINYL ALCOHOL) POLYMERS, USES AND PREPARATION THEREOF | Valorisation-Recherche, Société en Commandite (CA) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007143848-A1 | POLY (VINYL ALCOHOL) POLYMERS, USES AND PREPARATION THEREOF | Valorisation-Recherche, Société en Commandite (CA) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100038297-A1 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof | PUF60, VCL, PARG | CTSK 4392/4885CA1 3289/4885CA2 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.